BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2025 3:57:03 AM | Browse: 86 | Download: 293
 |
Received |
|
2025-08-19 01:32 |
|
Peer-Review Started |
|
2025-08-19 01:32 |
|
First Decision by Editorial Office Director |
|
2025-09-04 07:16 |
|
Return for Revision |
|
2025-09-04 07:16 |
|
Revised |
|
2025-09-17 02:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-31 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-31 08:19 |
|
Articles in Press |
|
2025-10-31 08:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-20 02:15 |
|
Publish the Manuscript Online |
|
2025-11-26 03:57 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan Liu, Xiao-Qian Shan, Yu-Jiao Li, Wei-Li Gao and Lan Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Lan Zhao, Academic Fellow, /, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No. 88 Changling Road, Xiqing District, Tianjin 300381, China. lanzhao69@163.com |
| Key Words |
Human umbilical cord mesenchymal stem cells; Diabetes; Diabetic kidney disease; Metabolic dysregulation; Metabolic dysfunction-associated steatotic liver disease; Diabetic complications |
| Core Tip |
This letter to the editor focuses on investigating how human umbilical cord mesenchymal stem cells (hUC-MSCs) contribute to diabetic kidney damage. At the same time, explore the similarities and differences of hUC-MSCs in treating metabolic dysfunction-associated steatotic liver disease and diabetic kidney disease. There are benefits of using hUC-MSCs to treat metabolic disorders. Future studies on the relationship between hUC-MSCs and the management of metabolic disorders ought to be promoted. |
| Publish Date |
2025-11-26 03:57 |
| Citation |
Liu Y, Shan XQ, Li YJ, Gao WL, Zhao L. Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease. World J Stem Cells 2025; 17(11): 113201 |
| URL |
https://www.wjgnet.com/1948-0210/full/v17/i11/113201.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v17.i11.113201 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
